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Introduction
Improved outcomes for normoglycaemic patients suffer-
ing acute myocardial infarction (AMI) over the last decade
have not been matched by similar improvements in mor-
tality for diabetic patients despite similar levels of baseline
risk and appropriate medical therapy. The reasons for this
disparity in outcome are not completely understood.
Purpose
The purpose of this study was to determine if peri-infarct
glycaemic control has an impact on myocardial infarct
size, left ventricular ejection fraction (LVEF) and progno-
sis.
Methods
Ninety-three patients with first acute myocardial infarc-
tion (AMI) were studied. 22 patients had diabetes mellitus
(DM) based on prior history or admission blood glucose
≥ 11.1 mmol/l. 13 patients had dysglycaemia (admission
blood glucose ≥ 7.8 mmol/l but <11.1 mmol/l) and 58
patients had normoglycaemia (admission blood glucose
<7.8 mmol/l). Patients underwent CMR imaging at index
presentation and at median follow-up of 11 months. The
CMR protocol was identical for all patients and included
cine imaging and late gadolinium enhancement.
Results
Patients with dysglycaemia and DM had larger infarct
sizes by CMR than normoglycaemic patients, at baseline
(mean (standard deviation, SD) % LV scar 23.0 (10.9),
25.6 (12.9) and 15.8 (10.3) respectively, overall p =
0.001) and at 11 months (mean (SD) % LV scar 17.6
(8.9), 19.1 (9.6) and 12.4 (7.8) respectively, overall p =
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Graph demostrating mean % LV scar at baseline and at median foll w up 11 onths accordeing to glycaemic statusFigure 1
Graph demostrating mean % LV scar at baseline and 
at median follow up 11 months accordeing to glycae-
mic status. The error bars represent the 95% confidence 
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0.017) (Figure 1). Patients with dysglycaemia and DM
also had lower LVEF than normoglycaemic patients at
baseline and at 11 months (not significant) and had lower
event-free survival at 18 months (p = 0.005) (Figure 2).
Conclusion
This study highlights the prognostic significance of peri-
infarct glycaemic control in patients with AMI. Patients
with dysglycaemia or DM appear to have larger infarct
sizes and lower LVEF as determined by CMR, than normo-
glycaemic patients. This may, in part, account for their
adverse prognosis.
Kaplan-Meier curves demonstratin event-free survival for all patients subdivided by glycaemic statusFigure 2
Kaplan-Meier curves demonstratin event-free sur-
vival for all patients subdivided by glycaemic status.Page 2 of 2
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